Prognostic value of inflammatory response biomarkers using peripheral blood and [18F]-FDG PET/CT in advanced NSCLC patients treated with first-line chemo- or immunotherapy
Romain‐David Seban, Jean‐Baptiste Assié, Etienne Giroux‐Leprieur, Marie-Ange Massiani, G. Bonardel, C. Chouaïd, Nicolas Deleval, Capucine Richard, Laura Mezquita, Nicolas Girard, Laurence Champion
Topics & Concepts
MedicineInternal medicineRetrospective cohort studyGastroenterologyOncologyProportional hazards modelCohortImmunotherapyLymphocyteAbsolute neutrophil countChemotherapyCancerNeutropeniaInflammatory Biomarkers in Disease PrognosisCancer Immunotherapy and BiomarkersFerroptosis and cancer prognosis